Phase III MANIFEST-2: Pelabresib + Ruxolitinib vs Placebo + Ruxolitinib in JAK Inhibitor Treatment-Naive Myelofibrosis | Zendy

Claire Harrison | Zendy; Vikas Gupta | Zendy; Aaron T. Gerds | Zendy; Raajit K. Rampal | Zendy; Srđan Verstovšek | Zendy; Moshe Talpaz | Zendy; JeanJacques Kiladjian | Zendy; Ruben A. Mesa | Zendy; Andrew Kuykendall | Zendy; Alessandro M. Vannucchi | Zendy; Francesca Palandri | Zendy; Sebastian Grosicki | Zendy; Timothy Devos | Zendy; Éric Jourdan | Zendy; Mariëlle J. Wondergem | Zendy; Haifa Kathrin AlAli | Zendy; Veronika BuxhoferAusch | Zendy; Alberto ÁlvarezLarrán | Zendy; Andrea Patriarca | Zendy; Marina Kremyanskaya | Zendy; Adam J. Mead | Zendy; Sanjay Akhani | Zendy; Yuri Sheikine | Zendy; Gozde Colak | Zendy; John Mascarenhas | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Phase III MANIFEST-2: Pelabresib + Ruxolitinib vs Placebo + Ruxolitinib in JAK Inhibitor Treatment-Naive Myelofibrosis

Author(s) -

Claire Harrison,

Vikas Gupta,

Aaron T. Gerds,

Raajit K. Rampal,

Srđan Verstovšek,

Moshe Talpaz,

JeanJacques Kiladjian,

Ruben A. Mesa,

Andrew Kuykendall,

Alessandro M. Vannucchi,

Francesca Palandri,

Sebastian Grosicki,

Timothy Devos,

Éric Jourdan,

Mariëlle J. Wondergem,

Haifa Kathrin AlAli,

Veronika BuxhoferAusch,

Alberto ÁlvarezLarrán,

Andrea Patriarca,

Marina Kremyanskaya,

Adam J. Mead,

Sanjay Akhani,

Yuri Sheikine,

Gozde Colak,

John Mascarenhas

Publication year - 2022

Publication title -

future oncology

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 0.857

H-Index - 72

eISSN - 1744-8301

pISSN - 1479-6694

DOI - 10.2217/fon-2022-0484

Subject(s) - ruxolitinib , medicine , myelofibrosis , myeloproliferative neoplasm , placebo , clinical trial , oncology , extramedullary hematopoiesis , bone marrow , haematopoiesis , pathology , stem cell , alternative medicine , biology , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Address

About

Learn

Download the Zendy App

Discover

Explore